Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesThe Effect of Prior Bisphosphonate Therapy on the Subsequent BMD and Bone Turnover Response to Strontium Ranelate
Journal of Bone and Mineral Research, 10/02/09
Middleton ET et al. – After bisphosphonates bone turnover remains suppressed for up to 6 months with blunting of the BMD response to strontium ranelate during this time. After 6 months BMD increased in the spine but not at the hip or heel.
Related Articles
Extended Use of Intravenous Bisphosphonate Therapy for the Prevention of Skeletal Complications in Patients with Cancer
Cancer Investigation, 11/16/09
Relevance Score: 68%
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/10/09
Relevance Score: 68%
Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy
The Journal of Urology, 10/16/09
Relevance Score: 67%
Bisphosphonates in breast cancer: teaching an old dog new tricks
Current Opinion in Oncology, 10/12/09
Relevance Score: 66%
Microbial Biofilms in Osteomyelitis of the Jaw and Osteonecrosis of the Jaw Secondary to Bisphosphonate Therapy
The Journal of the American Dental Association, 10/05/09
Relevance Score: 65%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures
Osteoporosis International, 12/14/09
Use of oral bisphosphonates and risk of venous thromboembolism: A population-based case-control study
Osteoporosis International, 12/14/09
Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice
Trials, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor